Preclinical Updates for Complement Regulators Using Gene Therapies
Time: 2:00 pm
day: Conference Day Two
Details:
- The benefits of using gene therapies to target complement mediated diseases
- Using a localised approach to target the eye and mitigate toxicity
- Updates in targeting Geographic Atrophy/Dry AMD
